Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial by Pignata, Sandro, Dr, Scambia, Giovanni, Prof, Katsaros, Dionyssios, Prof, Gallo, Ciro, Prof, Pujade-Lauraine, Eric, Prof, De Placido, Sabino, Prof, Bologna, Alessandra, MD, Weber, Beatrice, MD, Raspagliesi, Francesco, MD, Panici, Pierluigi Benedetti, Prof, Cormio, Gennaro, MD, Sorio, Roberto, MD, Cavazzini, Maria Giovanna, MD, Ferrandina, Gabriella, MD, Breda, Enrico, MD, Murgia, Viviana, MD, Sacco, Cosimo, MD, Cinieri, Saverio, MD, Salutari, Vanda, MD, Ricci, Caterina, MD, Pisano, Carmela, MD, Greggi, Stefano, MD, Lauria, Rossella, MD, Lorusso, Domenica, MD, Marchetti, Claudia, MD, Selvaggi, Luigi, Prof, Signoriello, Simona, PhD, Piccirillo, Maria Carmela, MD, Di Maio, Massimo, MD, Perrone, Francesco, MD

Get full text

Pazopanib plus weekly paclitaxel versus weekly paclitaxel alone for platinum-resistant or platinum-refractory advanced ovarian cancer (MITO 11): a randomised, open-label, phase 2 t... by Pignata, Sandro, Dr, Lorusso, Domenica, MD, Scambia, Giovanni, Prof, Sambataro, Daniela, MD, Tamberi, Stefano, MD, Cinieri, Saverio, MD, Mosconi, Anna M, MD, Orditura, Michele, MD, Brandes, Alba A, MD, Arcangeli, Valentina, MD, Panici, Pierluigi Beneditti, Prof, Pisano, Carmela, MD, Cecere, Sabrina C, MD, Di Napoli, Marilena, MD, Raspagliesi, Francesco, MD, Maltese, Giuseppa, MD, Salutari, Vanda, MD, Ricci, Caterina, MD, Daniele, Gennaro, MD, Piccirillo, Maria Carmela, MD, Di Maio, Massimo, MD, Gallo, Ciro, Prof, Perrone, Francesco, MD

Get full text

Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with meta... by Cremolini, Chiara, MD, Antoniotti, Carlotta, MD, Rossini, Daniele, MD, Lonardi, Sara, MD, Loupakis, Fotios, MD, Pietrantonio, Filippo, MD, Bordonaro, Roberto, MD, Latiano, Tiziana Pia, MD, Tamburini, Emiliano, MD, Santini, Daniele, Prof, Passardi, Alessandro, MD, Marmorino, Federica, MD, Grande, Roberta, MD, Aprile, Giuseppe, MD, Zaniboni, Alberto, MD, Murgioni, Sabina, MD, Granetto, Cristina, MD, Buonadonna, Angela, MD, Moretto, Roberto, MD, Corallo, Salvatore, MD, Cordio, Stefano, MD, Antonuzzo, Lorenzo, MD, Tomasello, Gianluca, MD, Masi, Gianluca, Prof, Ronzoni, Monica, MD, Di Donato, Samantha, MD, Carlomagno, Chiara, Prof, Clavarezza, Matteo, MD, Ritorto, Giuliana, MD, Mambrini, Andrea, MD, Roselli, Mario, Prof, Cupini, Samanta, MD, Mammoliti, Serafina, MD, Fenocchio, Elisabetta, MD, Corgna, Enrichetta, MD, Zagonel, Vittorina, MD, Fontanini, Gabriella, Prof, Ugolini, Clara, MD, Boni, Luca, MD, Falcone, Alfredo, Prof

Get full text

RECIST/CA-125 progression-free survival and the role of CA-125 surveillance in the phase III PAOLA-1/ENGOT-ov25 trial evaluating maintenance olaparib plus bevacizumab in patients w... by Hietanen, Sakari, MD, Pautier, Patricia, MD, Harter, Philipp, Cropet, Claire, Cinieri, Saverio, MD, Caballero, Cristina, Marth, Christian, MD PhD, Fujiwara, Hiroyuki, MD, PhD, Vergote, Ignace, MD, PhD, Colombo, Nicoletta, MD, Lotz, Jean-Pierre, Gropp-Meier, Martina, Dr med, Mosconi, Anna Maria, MD, Manso, Luis, MD PhD, Lefeuvre-Plesse, Claudia, MD, Lück, Hans-Joachim, MD, PhD, Lortholary, Alain, MD, Schnelzer, Andreas, MD, Dubot, Coraline, Ray-Coquard, Isabelle, Prof

Get full text